AUS
NZ
UK
CA
USA
IND
Healthcare
IXICO’s Momentum Builds as Growth Strategy Gains Ground
April 21, 2026 11:55 AM BST| By Vivek SinghIXICO’s growth story strengthens with rising demand, expanding order visibility, and strategic investment aimed at broadening its reach across clinical trials and healthcare ecosystems.
IXICO’s Growth Path: TechBio Strategy Gains Momentum
April 21, 2026 11:40 AM BST| By Vivek SinghIXICO advances its TechBio strategy with strong contract growth, expanding margins, and rising demand for CNS trial analytics, strengthening its long-term outlook in the clinical research space.
Chill Brands Restructure Plan Signals Strategic Shift Ahead
April 20, 2026 08:00 PM BST| By Vivek SinghHighlights,Shareholder meetings scheduled to clear pending matters,Capital reorganisation aims to reshape share structure,Move expected to support flexible future share issuance,Chill Brands Group is advancing a share capital overhaul alongside key s...
Genflow Biosciences Advances with Key RNA Collaboration
April 20, 2026 12:03 PM BST| By Vivek SinghHighlights,Major collaboration expands delivery technology access,Non-cash, non-dilutive structure supports development path,Research focus strengthened through advanced nanoparticle platform,Genflow Biosciences strengthens its research and developme...
Genflow Biosciences FTSE 350 Biotech Shares Rise on New Deal?
April 20, 2026 12:03 PM BST| By Vivek SinghGenflow Biosciences highlights its FTSE 350 presence through collaboration, advancing gene therapy research and integrating delivery technologies in the biotechnology and healthcare innovation landscape.
GSK Secures China Nod for Blenrep in Cancer Care
April 20, 2026 10:57 AM BST| By Vivek SinghHighlights,China approval expands oncology reach,New therapy option for relapsed patients,Clinical trial data supports treatment impact,GSK gains regulatory clearance in China for Blenrep combination therapy, strengthening its oncology portfolio and...
Why Are GSK Shares Rising in FTSE 100 on Pipeline Focus?
April 20, 2026 08:45 AM BST| By Vivek SinghGSK’s FTSE 100 presence reflects recent share momentum, ongoing pipeline progress, and continued focus on innovation within the pharmaceutical sector and evolving market conditions.
Did Genflow Biosciences sign a new mRNA partnership deal?
April 20, 2026 08:34 AM BST| By Vivek SinghGenflow Biosciences expands its FTSE 350 presence with a collaboration on mRNA delivery, highlighting progress in gene therapy and lipid nanoparticle technology innovation.
Animalcare Moves Forward with Takeover Agreement by Charterhouse
April 16, 2026 01:22 PM BST| By Vivek SinghAnimalcare has entered a definitive agreement to be acquired by Charterhouse Capital Partners, marking a significant development in the animal health industry with a focus on long-term international growth.
FTSE AIM 100 Index Focus: NIOX Group Healthcare Activity
April 16, 2026 07:27 AM BST| By Vivek SinghHealthcare stocks across FTSE AIM indices reflect sector participation through diagnostic technologies, corporate developments, and clinical integration within the UK equity market.
Kooth and Ftse 350 Index Presence in UK Digital Healthcare Space
April 14, 2026 08:03 AM BST| By Vivek SinghKooth plc operates in digital mental healthcare across the UK, delivering accessible online services through public sector partnerships within the AIM market segment.
EKF Diagnostics Expands Digital Sports Tech Reach Through Strategic Asset Acquisition
April 13, 2026 02:00 PM BST| By Vivek SinghEKF Diagnostics expands its sports performance capabilities through advanced wearable-integrated analytics technology, enhancing real-time biometric tracking and training insights within a connected sports science ecosystem.
Cambridge Cognition Sees Strong Orders Momentum Build
April 13, 2026 01:41 PM BST| By Vivek SinghCambridge Cognition reports a notable rise in new sales orders, a stronger order pipeline, and improved financial stability despite earlier revenue pressure, supported by cost discipline and market expansion.
GSK Expands China Footprint With Exdensur Approval
April 12, 2026 08:19 PM BST| By Vivek SinghGSK’s China approval for Exdensur enhances its respiratory portfolio and highlights growing focus on biologics in global healthcare markets, especially across the LSE & FTSE stock market landscape.
Shield Therapeutics plc Narrows Loss Outlook in FTSE 350
April 12, 2026 09:38 AM BST| By Anmol KhazanchiShield Therapeutics reflects FTSE 350 healthcare trends through earnings updates, steady revenue growth, and expanding commercial strategies within the biopharmaceutical sector.
Is AstraZeneca Still in Focus After Strong Market Momentum?
April 10, 2026 08:08 PM BST| By Vivek SinghAstraZeneca continues to attract attention as valuation perspectives, earnings outlook, and market narratives shape how its share performance is interpreted across global healthcare markets.
EKF Diagnostics Slides Below Key Trend Line Amid FTSE AIM Focus
April 09, 2026 02:31 PM BST| By Team Kalkine MediaEKF Diagnostics (LSE:EKF) moved below a key long-term trend level as healthcare diagnostics activity and AIM market dynamics continue to shape sector performance.
Healthcare Pulse Within FTSE AIM 100 Index
April 08, 2026 05:34 PM BST| By Vivek SinghThe healthcare sector continues to evolve through innovation, research alignment, and global engagement, shaping its presence within the UK market and reinforcing its role in broader economic structures.
FTSE 350: BSF Enterprise (LSE:BSFA) Volume Rises After Unveil
April 07, 2026 02:21 PM BST| By Vivek SinghBSF Enterprise PLC highlights biotech advancements in the FTSE 350, introducing engineered materials that merge scientific innovation with luxury design and public exhibition visibility.
-Copy_02_19_2025_19_14_16_993300.jpg)
Eco Animal Health Expands Veterinary Footprint Across FTSE Market
April 06, 2026 04:33 PM BST| By Vivek SinghEco Animal Health Group operates in the veterinary pharmaceutical sector, supporting global livestock health while maintaining a presence within key UK market indices.
